Amygdalin has been promoted as an alternative cancer treatment, but clinical studies have not demonstrated its efficacy. Major health organizations, including the American Cancer Society and the National Cancer Institute, do not support its use due to a lack of scientific evidence and safety concerns. The mechanism by which amygdalin is purported to kill cancer cells is not scientifically validated.
